Cargando…
Human Immunodeficiency Virus 1 (HIV-1): Viral Latency, the Reservoir, and the Cure
An estimated 37 million people globally suffer from Human Immunodeficiency Virus-1 (HIV-1) infection with 1.7 million newly acquired infections occurring on average each year. Although crucial advances in combined antiretroviral therapy (ART) over the last two decades have transformed an HIV-1 diagn...
Autor principal: | Ventura, John D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
YJBM
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7513431/ https://www.ncbi.nlm.nih.gov/pubmed/33005119 |
Ejemplares similares
-
Human Immunodeficiency Virus (HIV)-1 Integration Sites in Viral Latency
por: Rezaei, Simin D., et al.
Publicado: (2015) -
HIV-1 Latency and Viral Reservoirs: Existing Reversal Approaches and Potential Technologies, Targets, and Pathways Involved in HIV Latency Studies
por: Khanal, Sushant, et al.
Publicado: (2021) -
HIV interactions with monocytes and dendritic cells: viral latency and reservoirs
por: Coleman, Christopher M, et al.
Publicado: (2009) -
Future approaches to clearing the latent human immunodeficiency virus reservoir: Beyond latency reversal
por: Hayes, Alexander M.L.
Publicado: (2020) -
Recent developments in human immunodeficiency virus-1 latency research
por: Chan, Chi Ngai, et al.
Publicado: (2013)